- NHF members reside in these countries:
Why Antidepressants Cause Brain Damage, Breast Cancer And Early Mortality
By Byron J. Richards, CCN
May 27, 2011
When you see a headline like this in the news, “Anti-inflammatory Drugs Reduce the Effectiveness of SSRI Antidepressants,” what does it make you think? The impression given is that if you are taking an SSRI then you shouldn’t take any pain pills if you want the antidepressants to work – which is the clear message of the press release that accompanied the study. If you are developing “health brains” on your shoulders then you would realize that SSRI antidepressants must be “working” by some type of inflammatory method. It is now common knowledge that low-grade excess inflammation is behind virtually every disease of aging. The obvious contradictions don’t add up to health. Pulling strings further, as I explain in this article, leads to an understanding as to why antidepressants are associated with an increased risk of breast cancer, brain damage over time, and a significantly increased risk of early mortality – information the pill pushers at Big Pharma would prefer you never understood.
The study showed that the use of anti-inflammatory pain medications, such as ibuprofen, aspirin and naproxen, reduced the “effectiveness” of the most widely used type of antidepressants. A combination of an animal study and a large scale human data evaluation led researchers to conclude that the typical response rate to SSRIs of 54% dropped to 40%.
“The mechanism underlying these effects is not yet clear. Nevertheless, our results may have profound implications for patients, given the very high treatment resistance rates for depressed individuals taking SSRIs,” notes Dr. Jennifer Warner-Schmidt. “Many elderly individuals suffering from depression also have arthritic or related diseases and as a consequence are taking both antidepressant and anti-inflammatory medications. Our results suggest that physicians should carefully balance the advantages and disadvantages of continuing anti-inflammatory therapy in patients being treated with antidepressant medications.”
I guess she is trying to say that if you want to try to help your brain pain you may need to live with your physical pain – a testament to the ineptitude of Western Medicine’s drug-based therapies. The real story is what isn’t being said or explained – as almost nobody would ever take an SSRI antidepressant for any length of time if they understood what was actually just discovered.
These researchers noted that SSRIs provoked a release of pro-inflammatory signals in the brain, TNFa and IFNy, which were blocked by the anti-inflammatory drugs. TNFa (tumor necrosis factor alpha) is an inflammatory cytokine produced by immune cells and by glial cells in the brain – in response to a problem. For example, overweight people make far too much TNFa in their inflamed white adipose tissue, which can travel up to the brain, cross the blood brain barrier, and induce brain-inflammation resulting in the cognitive decline and depression that is so closely linked to obesity. IFNy (interferon gamma) is a potent activator of an immune-related response – typically to viral infection or a tumor. It specifically boosts up the production of highly inflammatory nitric oxide (iNOS), a compound that is essential for an immune system battle and highly inflammatory to healthy nerve cells and to the cardiovascular system.
So how on earth could taking these brain-inflammatory SSRI antidepressant drugs help a person feel better mentally?
The BDNF Response to Health and Trauma
BDNF (brain-derived neurotrophic factor) is one of the most potent healing compounds in your brain. Adequate BDNF is needed for brain plasticity, cognitive intelligence, optimal learning, positive mood, etc. In other words BDNF is your brain rejuvenation compound. BDNF can prevent and treat Alzheimer’s disease. BDNF is even active outside your brain wherein it helps your muscles burn fat! A lack of BDNF sets the stage for addictive behavior, including compulsive overeating. Those with the lowest levels of BDNF have the worst depression.
You can activate BDNF with aerobic exercise, even consistent moderate aerobics. Aerobics in older adults has been shown to stop brain shrinkage and boost BDNF while preventing depression. There are many nutrients that facilitate the production and release of BDNF (DHA, pantethine, acetyl-l-carnitine, zinc, blueberries, curcumin, niacin, DHEA, and likely many others). Nutrients work very well to maintain BDNF levels in the face of high levels of stress, as clicking on any of the study links in the previous sentence will explain to you. In order to properly activate BDNF it also requires proper function of thyroid hormone – an issue that is problematic in many people with depression.
BDNF production in your brain occurs within glial cells (astrocytes). It is very important to understand that BDNF production can be activated by multiple signals coming into the glial cells, not just one type of input. In other words, we have glial cell activation in response to healthy behaviors like exercise and good nutrition, part of the ongoing process of keeping your brain rejuvenated and in tip-top working condition. In animal experiments following stroke, voluntary exercise helps produce high levels of BDNF and nerve regeneration whereas forced exercise does not.
BDNF is also activated during times of brain injury, so as to repair the injury. Nerve cells do not split and divide like other cells in your body. Rather, nerve cells must either fix themselves or have a strategy to develop new nerve growth, and both processes require BDNF. Thus, one way to stimulate BDNF is to injure nerve cells.
It is this latter strategy that SSRI antidepressants utilize – in a manner never intended by Mother Nature. The details of this rather bizarre method of operation are explained in a detailed review article. In brief, one way SSRIs are supposed to work is by enhancing the flow of serotonin – an effect that would be felt immediately upon taking. It is well recognized that an additional mechanism is in play, as for many it takes several weeks or longer before mood seems to improve. This latter effect is due to the SSRI medication progressively accumulating in glial cells, inducing a highly inflammatory toxic response, and triggering the release of BDNF. Now you can understand why taking anti-inflammatory drugs would interfere with SSRI function.
It should be understood that such a strategy to boost BDNF production is highly problematic and can just as readily result in suicide or worsened depression. First of all, a person who is depressed is lacking BDNF. This means their credit cards for BDNF have been maxed out trying to cope with the stress in their life. In essence, SSRI antidepressants are like getting a new BDNF credit card from a loan shark. The interest rates are astronomically high, i.e., the loan is given in the form of excitotoxic brain cell injury. Talk about robbing Peter to pay Paul. A very short term remedy at best.
According to the above review article the method of BDNF activation by SSRI antidepressants utilizes a specific gene signaling pathway called TrkB (Tropomyosin-associated kinase). The overexpression of this particular gene signal is known to cause breast cancer. It is not that BDNF causes breast cancer. Indeed, just about every nutrient listed above that boosts BDNF production naturally also protects against breast cancer. This is the difference between nutrition and drugs. Nutrients and exercise act in harmony with the brain to bolster its natural function, while nourishing and protecting other areas of the body. In this case SSRIs are manipulating an injury recovery strategy to boost BDNF by actually poisoning brain cells. This strategy was never intended to be used on an ongoing basis. It is quite clear that the TNFa activation of BDNF can have deleterious effects on the nervous systems and may not help BDNF production at all. The science provides a direct link to cancer, especially breast cancer.
Breast Cancer and SSRI Use
Human data regarding SSRI use and breast cancer is highly controversial. The reason it is controversial is due to Big Pharma-funded “scientists for hire” who crank out studies that say there is no risk. This is only one aspect of the blatant and fraudulent misrepresentation of SSRI risks and benefits.
This issue came front and center in an April 2011 open access article published in Plos One that reviewed 61 studies regarding breast and ovarian cancer and antidepressant use. The overall data showed that there was an 11% increased risk for breast and ovarian cancer associated with all types of antidepressants. The association between the SSRI type of antidepressants and cancer was stronger than for any other type of antidepressant, with all SSRI studies but one showing an increased risk of female cancer. Additionally, this April 2011 study also evaluated the financial ties of study authors to the companies that make antidepressants. Shockingly, none of the 15 researchers with financial ties to the industry found any risk for breast/ovarian cancer in the studies they conducted, whereas 43% of the researchers without industry ties found clear evidence of cancer risk. The authors called for more research to determine the exact nature of this risk, since 10% - 15% of women are on these drugs. Don’t expect the FDA to do anything meaningful any time soon.
Another angle to this problem is that women with breast cancer are often put on SSRI medications because they are depressed about their health. According to a February 2010 open access article published in the British Medical Journal, the SSRI antidepressants block the effectiveness of Tamoxifen causing up to a 91% increased risk of death from breast cancer in a 2.5 year period of follow up.
The Disturbing Picture of the Cruel SSRI Scam
The SSRI literature cover-up extends far beyond attempting to hide or negate the link to breast cancer. The fraudulent scam goes to the heart of the matter, i.e., whether the drugs even work very well at all.
In 2008 the New England Journal of Medicine exposed the extent of the antidepressant deception. The great majority of negative SSRI studies were never published. A whistleblower who had worked at the FDA and was familiar with the data forced the data to public view. It showed 37 studies the FDA considered positive were published, whereas only 3 negative studies were published. 33 studies the FDA considered negative or questionable were either not published (22) or published with spin to look positive when they were not (11). This made antidepressant studies appear 96% positive in the literature, when in fact the studies were only 51% positive. In fact, as Newsweek magazine explained in January of 2010, that “benefit” was hardly any different than the placebo.
On the other hand, rather extreme side effect data from taking SSRI antidepressants continues to pour in. In November of 2008 it was shown that anyone over the age of 50 taking SSRIs on a continual basis had double the risk for fractures, as excessive serotonin production directly blocks new bone formation. In March of 2009 it was reported in a large study of women that antidepressant use, independent of other variables, was linked to a statistically increased risk of sudden cardiac death. In December of 2009 researchers reported that in 136,000 postmenopausal women taking SSRIs there was a 45% increased risk of stroke of any kind, a 32% increased risk of mortality from any cause, a 212% increased risk of a hemorrhagic stroke, and a 210% increased risk that the stroke damage would be so severe it would cause death. As mentioned at the beginning of this article, the increased rate of inflammation in the brain, especially activating highly inflammatory iNOS in response to INFy, is a clear mechanism that could cause these dangerous strokes in the brain.
The issue of cardiovascular, breast cancer, and mortality adverse effects from SSRIs is far from settled. The industry will do everything in its power to pay scientists to publish studies that state or imply there are no problems. The battle will go on for years, with massive litigation expenses hanging over the heads of Big Pharma. The FDA, as always, is missing in action. However, to the person taking an SSRI to feel better it is clear that the drugs work by inflammatory mechanisms that are not healthy over the long haul and possibly even in the short term. SSRIs are a credit card at best and one day you will need to pay up.
While I am well aware of people who feel symptomatic improvement from taking antidepressants, this information serves as a wake-up call and hopefully will help such people find alternative solutions such as exercise, weight loss if overweight, a better diet, dietary supplements that can help boost BDNF, improved stress management skills, and non-drug psychotherapy as needed. Getting off SSRI medications requires that you work with your doctor – and the long term goal is to be off them because you don’t need them. I also have first hand knowledge of many people who have been injured by SSRI medications, including suicide. The fact that the SSRI medications, while helpful to some, are clinically proven to be no better than placebo, represents one of the great con jobs of all time on the unsuspecting American public.
Maybe Congress should investigate this issue instead of wasting time and taxpayer money on Barry Bonds and Roger Clemens.
Byron J. Richards, Board-Certified Clinical Nutritionist, nationally-renowned nutrition expert, and founder of Wellness Resources is a leader in advocating the value of dietary supplements as a vital tool to maintain health. He is an outspoken critic of government and Big Pharma efforts to deny access to natural health products and has written extensively on the life-shortening and health-damaging failures of the sickness industry.
His 25 years of clinical experience from the front lines of nutrition have made him a popular radio guest who callers find impossible to stump. He has personally developed 75 unique nutraceutical-gradenutritional supplement formulas with a focus on thyroid nutrition, healthy weight loss supplements, cardiovascular nutrition, and stress management.